A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy

Biomaterials

Volumn 86, Issue , 2016, Pages 92-105

  Lee, Shin Yu ^a   Yang, Chia Ying ^a   Peng, Cheng Liang ^a,b   Wei, Ming Feng ^a   Chen, Ke Cheng ^a   Yao, Cheng Jung ^a,c   Shieh, Ming Jium ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Colorectal cancer; Micelleplex; Micelles; MRI; SN 38; VEGF siRNA

Indexed keywords

CARDIOVASCULAR SYSTEM; CHEMOTHERAPY; DIAGNOSIS; DISEASES; ENDOTHELIAL CELLS; GENE TRANSFER; GENES; MAGNETIC RESONANCE IMAGING; MICELLES; MULTILAYER FILMS; ONCOLOGY; TUMORS;

COLORECTAL CANCER; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; MICELLEPLEX; POLY (EPSILONCAPROLACTONE); SMALL INTERFERING RNA (SIRNA); SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF SIRNA;

GENE THERAPY;

COPOLYMER; FIRTECAN; MACROGOL; NANOCARRIER; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VASCULOTROPIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DEXTRAN; DRUG CARRIER; FERUMOXTRAN-10; IRINOTECAN; MACROGOL DERIVATIVE; MAGNETITE NANOPARTICLE; METHACRYLIC ACID DERIVATIVE; MICELLE; POLYCAPROLACTONE; POLYESTER; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSAFETY; CANCER CHEMOTHERAPY; CANCER INHIBITION; COLON ADENOCARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RELEASE; FEMALE; GENE DELIVERY SYSTEM; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RNA STABILITY; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLON; COLORECTAL NEOPLASMS; DRUG EFFECTS; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PROCEDURES; RECTUM; RNAI THERAPEUTICS; THERANOSTIC NANOMEDICINE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; COLON; COLORECTAL NEOPLASMS; DEXTRANS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MAGNETITE NANOPARTICLES; METHACRYLATES; MICE, INBRED BALB C; MICE, NUDE; MICELLES; POLYESTERS; POLYETHYLENE GLYCOLS; RECTUM; RNA, SMALL INTERFERING; RNAI THERAPEUTICS; THERANOSTIC NANOMEDICINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84975684134     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.01.068     Document Type: Article

References (71)

1. Meyerhardt J.A., Mayer R.J. Systemic therapy for colorectal cancer. N. Engl. J. Med. 2005, 352:476-487. 10.1056/NEJMra040958.
2. Loupakis F., Cremolini C., Masi G., Lonardi S., Zagonel V., Salvatore L., et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N. Engl. J. Med. 2014, 371:1609-1618. 10.1056/NEJMoa1403108.
3. Van Cutsem E., Köhne C.-H., Hitre E., Zaluski J., Chang Chien C.-R., Makhson A., et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 2009, 360:1408-1417. 10.1056/NEJMoa0805019.
4. Tol J., Koopman M., Cats A., Rodenburg C.J., Creemers G.J.M., Schrama J.G., et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N. Engl. J. Med. 2009, 360:563-572. 10.1056/NEJMoa0808268.
5. Takimoto C.H., Arbuck S.G. Topoisomerase I Targeting Agents: the Camptothecins. Cancer Chemother Biother Princ Pract 2001, 579-646. Lippincott Williams Wilkins, Philadelphia. third ed.
6. Sayari E., Dinarvand M., Amini M., Azhdarzadeh M., Mollarazi E., Ghasemi Z., et al. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. Int. J. Pharm. 2014, 473:304-315. 10.1016/j.ijpharm.2014.05.041.
7. Peng C.-L., Tsai H.-M., Yang S.-J., Luo T.-Y., Lin C.-F., Lin W.-J., et al. Development of thermosensitive poly(n-isopropylacrylamide-co-((2-dimethylamino) ethyl methacrylate))-based nanoparticles for controlled drug release. Nanotechnology 2011, 22:265608. 10.1088/0957-4484/22/26/265608.
8. Pal A., Khan S., Wang Y.F., Kamath N., Sarkar A.K., Ahmad A., et al. Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation. Anticancer Res. 2005, 25:331-341.
9. Lee P.-C., Chiou Y.-C., Wong J.-M., Peng C.-L., Shieh M.-J. Targeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibody. Biomaterials 2013, 34:8756-8765. 10.1016/j.biomaterials.2013.07.067.
10. Matsumura Y. Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect. Adv. Drug Deliv. Rev. 2011, 63:184-192. 10.1016/j.addr.2010.05.008.
11. Peng C.L., Lai P.S., Lin F.H., Yueh-Hsiu Wu S., Shieh M.J. Dual chemotherapy and photodynamic therapy in an HT-29 human colon cancer xenograft model using SN-38-loaded chlorin-core star block copolymer micelles. Biomaterials 2009, 30:3614-3625. 10.1016/j.biomaterials.2009.03.048.
12. Ferrara N., Hillan K.J., Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem. Biophys. Res. Commun. 2005, 333:328-335. 10.1016/j.bbrc.2005.05.132.
13. Ciombor K.K., Berlin J., Chan E. Aflibercept. Clin. Cancer Res. 2013, 19:1920-1925. 10.1158/1078-0432.CCR-12-2911.
14. Pieramici D.J., Rabena M.D. Anti-VEGF therapy: comparison of current and future agents. Eye (Lond) 2008, 22:1330-1336. 10.1038/eye.2008.88.
15. Castanotto D., Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 2009, 457:426-433. 10.1038/nature07758.
16. Tomar R.S., Matta H., Chaudhary P.M. Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 2003, 22:5712-5715. 10.1038/sj.onc.1206733.
17. Gary D.J., Lee H., Sharma R., Lee J.-S., Kim Y., Cui Z.Y., et al. Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes. ACS Nano 2011, 5:3493-3505. 10.1021/nn102540y.
18. Chen Y., Huang L. Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy. Expert Opin. Drug Deliv. 2008, 5:1301-1311. 10.1517/17425240802568505.
19. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., Park T.G. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J. Control Release 2006, 116:123-129. 10.1016/j.jconrel.2006.05.023.
20. Yu M.K., Park J., Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012, 2:3-44. 10.7150/thno.3463.
21. Shen J.-M., Gao F.-Y., Yin T., Zhang H.-X., Ma M., Yang Y.-J., et al. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. Pharmacol. Res. 2013, 70:102-115. 10.1016/j.phrs.2013.01.009.
22. Veiseh O., Gunn J.W., Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 2010, 62:284-304. 10.1016/j.addr.2009.11.002.
23. Elsherbini A.A.M., Saber M., Aggag M., El-Shahawy A., Shokier H.A.A. Magnetic nanoparticle-induced hyperthermia treatment under magnetic resonance imaging. Magn. Reson Imaging 2011, 29:272-280. 10.1016/j.mri.2010.08.010.
24. Choi W., Kim J.-Y., Heo S.U., Jeong Y.Y., Kim Y.H., Tae G. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging. J. Control Release 2012, 162:267-275. 10.1016/j.jconrel.2012.07.020.
25. Colombo M., Carregal-Romero S., Casula M.F., Gutiérrez L., Morales M.P., Böhm I.B., et al. Biological applications of magnetic nanoparticles. Chem. Soc. Rev. 2012, 41:4306-4334. 10.1039/c2cs15337h.
26. Zheng X., Lu J., Deng L., Xiong Y., Chen J. Preparation and characterization of magnetic cationic liposome in gene delivery. Int. J. Pharm. 2009, 366:211-217. 10.1016/j.ijpharm.2008.09.019.
27. Zhang J., Li X., Rosenholm J.M., Gu H. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles. J. Colloid Interface Sci. 2011, 361:16-24. 10.1016/j.jcis.2011.05.038.
28. Gao G.H., Lee J.W., Nguyen M.K., Im G.H., Yang J., Heo H., et al. pH-responsive polymeric micelle based on PEG-poly(β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area. J. Control Release 2011, 155:11-17. 10.1016/j.jconrel.2010.09.012.
29. Boyer C., Boutevin G., Robin J.J., Boutevin B. Study of the telomerization of dimethylaminoethyl methacrylate (DMAEMA) with mercaptoethanol. Application to the synthesis of a new macromonomer. Polym. Guildf. 2004, 45:7863-7876. 10.1016/j.polymer.2004.09.020.
30. Duan K., Zhang X., Tang X., Yu J., Liu S., Wang D., et al. Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin. Colloids Surf. B Biointerfaces 2010, 76:475-482. 10.1016/j.colsurfb.2009.12.007.
31. Lee S.H., Mok H., Park T.G. Di- and triblock siRNA-PEG copolymers: PEG density effect of polyelectrolyte complexes on cellular uptake and gene silencing efficiency. Macromol. Biosci. 2011, 11:410-418. 10.1002/mabi.201000347.
32. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006, 6:2427-2430. 10.1021/nl061412u.
33. Li X., Li H., Liu G., Deng Z., Wu S., Li P., et al. Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery. Biomaterials 2012, 33:3013-3024. 10.1016/j.biomaterials.2011.12.042.
34. Kim H., Dae H.-M., Park C., Kim E.O., Kim D., Kim I.-H., et al. A highly sensitive magnetite nanoparticle as a simple and rapid stem cell labelling agent for MRI tracking. J. Mater. Chem. 2011, 21:7742. 10.1039/c1jm10247h.
35. Lin D., Huang Y., Jiang Q., Zhang W., Yue X., Guo S., et al. Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery. Biomaterials 2011, 32:8730-8742. 10.1016/j.biomaterials.2011.07.089.
36. Glodde M., Sirsi S.R., Lutz G.J. Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides. Biomacromolecules 2006, 7:347-356. 10.1021/bm050726t.
37. Han L., Tang C., Yin C. Effect of binding affinity for siRNA on the in vivo antitumor efficacy of polyplexes. Biomaterials 2013, 34:5317-5327. 10.1016/j.biomaterials.2013.03.060.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4.
39. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., Park T.G. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J. Control Release 2008, 129:107-116. 10.1016/j.jconrel.2008.03.008.
40. Peng C.-L., Shieh M.-J., Tsai M.-H., Chang C.-C., Lai P.-S. Self-assembled star-shaped chlorin-core poly(epsilon-caprolactone)-poly(ethylene glycol) diblock copolymer micelles for dual chemo-photodynamic therapies. Biomaterials 2008, 29:3599-3608. 10.1016/j.biomaterials.2008.05.018.
41. Peng C.L., Shih Y.H., Lee P.C., Hsieh T.M.H., Luo T.Y., Shieh M.J. Multimodal image-guided photothermal therapy mediated by 188Re-labeled micelles containing a cyanine-type photosensitizer. ACS Nano 2011, 5:5594-5607.
42. Cheng C.-C., Lu N., Peng C.-L., Chang C.-C., Mai F.-D., Chen L.-Y., et al. Targeting to overexpressed glucose-regulated protein 78 in gastric cancer discovered by 2D DIGE improves the diagnostic and therapeutic efficacy of micelles-mediated system. Proteomics 2012, 12:2584-2597. 10.1002/pmic.201100602.
43. Cheng C.-C., Huang C.-F., Ho A.-S., Peng C.-L., Chang C.-C., Mai F.-D., et al. Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided (111)In-labeled polymeric micelles. Int. J. Nanomedicine 2013, 8:1385-1391. 10.2147/IJN.S42003.
44. Lai S.-M., Hsiao J.-K., Yu H.-P., Lu C.-W., Huang C.-C., Shieh M.-J., et al. Polyethylene glycol-based biocompatible and highly stable superparamagnetic iron oxide nanoclusters for magnetic resonance imaging. J. Mater. Chem. 2012, 22:15160. 10.1039/c2jm32086j.
45. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46:6387-6392.
46. Zhang J.A., Xuan T., Parmar M., Ma L., Ugwu S., Ali S., et al. Development and characterization of a novel liposome-based formulation of SN-38. Int. J. Pharm. 2004, 270:93-107. 10.1016/j.ijpharm.2003.10.015.
47. Corot C., Robert P., Idée J.-M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 2006, 58:1471-1504. 10.1016/j.addr.2006.09.013.
48. Bagri A., Berry L., Gunter B., Singh M., Kasman I., Damico L.A., et al. Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy. Clin. Cancer Res. 2010, 16:3887-3900. 10.1158/1078-0432.CCR-09-3100.
49. Lungwitz U., Breunig M., Blunk T., Göpferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 2005, 60:247-266. 10.1016/j.ejpb.2004.11.011.
50. Eliyahu H., Barenholz Y., Domb A.J. Polymers for DNA delivery. Molecules 2005, 10:34-64. 10.3390/10010034.
51. Lv H., Zhang S., Wang B., Cui S., Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control Release 2006, 114:100-109. 10.1016/j.jconrel.2006.04.014.
52. Zhang S., Xu Y., Wang B., Qiao W., Liu D., Li Z. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J. Control Release 2004, 100:165-180. 10.1016/j.jconrel.2004.08.019.
53. Oupický D., Koňák Č., Dash P.R., Seymour L.W., Ulbrich K. Effect of albumin and polyanion on the structure of DNA complexes with polycation containing hydrophilic nonionic block. Bioconjug. Chem. 1999, 10:764-772. 10.1021/bc990007.
54. Ogris M., Brunner S., Schüller S., Kircheis R., Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 1999, 6:595-605. 10.1038/sj.gt.3300900.
55. Verbaan F.J., Oussoren C., van Dam I.M., Takakura Y., Hashida M., Crommelin D.J.A., et al. The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int. J. Pharm. 2001, 214:99-101. 10.1016/S0378-5173(00)00642-6.
56. Eliyahu H., Servel N., Domb A.J., Barenholz Y. Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther. 2002, 9:850-858. 10.1038/sj.gt.3301705.
57. Xu P., Van Kirk E.a., Murdoch W.J., Zhan Y., Isaak D.D., Radosz M., et al. Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles. Biomacromolecules 2006, 7:829-835. 10.1021/bm050902y.
58. Sun X., Zhang N. Cationic polymer optimization for efficient gene delivery. Mini Rev. Med. Chem. 2010, 10:108-125.
59. Yao J., Ruan Y., Zhai T., Guan J., Tang G., Li H., et al. ABC block copolymer as "smart" pH-responsive carrier for intracellular delivery of hydrophobic drugs. Polym. Guildf. 2011, 52:3396-3404. 10.1016/j.polymer.2011.05.039.
60. Apopa P.L., Qian Y., Shao R., Guo N.L., Schwegler-Berry D., Pacurari M., et al. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol. 2009, 6:1.
61. Keenan C.R., Goth-Goldstein R., Lucas D., Sedlak D.L. Oxidative stress induced by zero-valent iron nanoparticles and Fe(II) in human bronchial epithelial cells. Environ. Sci. Technol. 2009, 43:4555-4560.
62. Kim H.S., Oh S.Y., Joo H.J., Son K.-R., Song I.-C., Moon W.K. The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. NMR Biomed. 2010, 23:514-522.
63. Lunov O., Syrovets T., Büchele B., Jiang X., Röcker C., Tron K., et al. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 2010, 31:5063-5071.
64. Soenen S.J.H., Nuytten N., De Meyer S.F., De Smedt S.C., De Cuyper M. High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling. Small 2010, 6:832-842.
65. Soenen S.J.H., Himmelreich U., Nuytten N., De Cuyper M. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 2011, 32:195-205.
66. Li M., Kim H.S., Tian L., Yu M.K., Jon S., Moon W.K. Comparison of two ultrasmall superparamagnetic iron oxides on cyto-toxicity and MR imaging of tumors. Theranostics 2012, 2:76-85.
67. Cabral H., Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. J. Control Release 2014, 190:465-476.
68. Saraswathy M., Gong S. Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment. Mater Today 2014, 17:298-306. 10.1016/j.mattod.2014.05.002.
69. Strebhardt K., Ullrich A. Targeting polo-like kinase 1 for cancer therapy. Nat. Rev. Cancer 2006, 6:321-330.
70. Han M., Lv Q., Tang X.-J., Hu Y.-L., Xu D.-H., Li F.-Z., et al. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. J. Control Release 2012, 163:136-144. 10.1016/j.jconrel.2012.08.020.
71. Yhee J.Y., Song S., Lee S.J., Park S.-G., Kim K.-S., Kim M.G., et al. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. J. Control Release 2015, 198:1-9. 10.1016/j.jconrel.2014.11.019.